Nucleic acid–based technology is now at a point where the field of transfusion medicine is
ready for its widespread application. In the donor center, genotyping of red blood cell (RBC) …

In the context of transfusion medicine, alloimmunization most often refers to the development
of antibodies to non-ABO red blood cell (RBC) antigens following pregnancy, transfusion, or …

Background: Serological safety is an integral part of overall safety for blood banks.
Emphasis is on the use of routinue Red Blood Cell (RBC) antibody screen test, at set time …

Disclosed are methods of for constructing a bead-displayed library of oligonucleotide probes
(or sequence-modified capture moieties such as protein-nucleic acid conjugates) by ligation …

Introducción: los estudios inmunohematológicos que se realizan a los donantes de sangre
se orientan a proporcionar al receptor una terapia transfusional compatible con el sistema …

Unique issues in blood donation and blood transfusion regarding African Americans (AA) in
the United States span the donation process, manufacturing of products, and hospital …

BACKGROUND Warm‐reactive autoantibodies (WAAs) are the most common cause of
autoimmune hemolytic anemia (AIHA) and can also be present without clinically significant …

Red blood cell alloimmunization remains a major complication for transfusion-dependent
patients, but immune factors governing risk for alloimmunization are unknown. We …

Blood group antigens (BGAs) can act as functional molecules but also can evoke
autoantibodies and alloantibodies, causing autoimmune hemolytic anemia, hemolytic …

Monoclonal antibodies such as daratumumab that target antigens that are also expressed
on red blood cells impede blood group typing. The preferred approach to potential …